CPEB1-AS1

Across TCGA pan-cancer cohorts, CPEB1-AS1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of CPEB1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where CPEB1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CPEB1-AS1 is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

KIRP, UCEC, and BRCA are the cancer types where CPEB1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CPEB1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.077	.003	5	view →
UCEC	All	All	−0.240	<.001	4	view →
BRCA	All	All	−0.028	.002	4	view →
COAD	All	All	−0.025	<.001	4	view →
BLCA	Male	IV	−0.140	.016	2	view →
LUAD	Female	All	−0.074	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

CPEB1-AS1–KIRP

Open the KIRP breakdown →